Furthermore, suppression of the integrin/Akt (Protein kinase B) survival signal has been recognized as a novel strategy to induce apoptosis and restore drug sensitivity in lung cancer cells [16,17,18]. This evidence concerns the gene AKT1 and lung carcinoma.